Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019 - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …
Cancer epigenetics in clinical practice
Cancer development is driven by the accumulation of alterations affecting the structure and
function of the genome. Whereas genetic changes disrupt the DNA sequence, epigenetic …
function of the genome. Whereas genetic changes disrupt the DNA sequence, epigenetic …
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
Epigenetics is dynamic and heritable modifications to the genome that occur independently
of DNA sequence. It requires interactions cohesively with various enzymes and other …
of DNA sequence. It requires interactions cohesively with various enzymes and other …
Histone modifications and cancer
JE Audia, RM Campbell - Cold Spring Harbor …, 2016 - cshperspectives.cshlp.org
Histone posttranslational modifications represent a versatile set of epigenetic marks
involved not only in dynamic cellular processes, such as transcription and DNA repair, but …
involved not only in dynamic cellular processes, such as transcription and DNA repair, but …
Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets
The majority of the human genome is not translated into proteins but can be transcribed into
RNA. Even though the resulting non-coding RNAs (ncRNAs) do not encode for proteins …
RNA. Even though the resulting non-coding RNAs (ncRNAs) do not encode for proteins …
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
The EZH2 histone methyltransferase is highly expressed in germinal center (GC) B cells and
targeted by somatic mutations in B cell lymphomas. Here, we find that EZH2 deletion or …
targeted by somatic mutations in B cell lymphomas. Here, we find that EZH2 deletion or …
Cancer genetics and epigenetics: two sides of the same coin?
JS You, PA Jones - Cancer cell, 2012 - cell.com
Epigenetic and genetic alterations have long been thought of as two separate mechanisms
participating in carcinogenesis. A recent outcome of whole exome sequencing of thousands …
participating in carcinogenesis. A recent outcome of whole exome sequencing of thousands …
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
Inactivation of the switch/sucrose nonfermentable complex component SMARCB1 is
extremely prevalent in pediatric malignant rhabdoid tumors (MRTs) or atypical teratoid …
extremely prevalent in pediatric malignant rhabdoid tumors (MRTs) or atypical teratoid …
Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
SK Knutson, S Kawano, Y Minoshima… - Molecular cancer …, 2014 - aacrjournals.org
Mutations within the catalytic domain of the histone methyltransferase EZH2 have been
identified in subsets of patients with non-Hodgkin lymphoma (NHL). These genetic …
identified in subsets of patients with non-Hodgkin lymphoma (NHL). These genetic …
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation
The ability to specifically upregulate genes in vivo holds great therapeutic promise. Here we
show that inhibition or degradation of natural antisense transcripts (NATs) by single …
show that inhibition or degradation of natural antisense transcripts (NATs) by single …